GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd (HKSE:01349) » Definitions » Price-to-Tangible-Book

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co (HKSE:01349) Price-to-Tangible-Book : 0.95 (As of Apr. 29, 2024)


View and export this data going back to 2002. Start your Free Trial

What is Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Price-to-Tangible-Book?

As of today (2024-04-29), Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co's share price is HK$2.18. Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co's Tangible Book per Share of Sep. 2023 for the quarter that ended in Sep. 2023 was HK$2.31. Hence, Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co's Price to Tangible Book Ratio of today is 0.95.

The historical rank and industry rank for Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co's Price-to-Tangible-Book or its related term are showing as below:

HKSE:01349' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 0.91   Med: 3.96   Max: 8.98
Current: 0.92

During the past 13 years, Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co's highest Price to Tangible Book Ratio was 8.98. The lowest was 0.91. And the median was 3.96.

HKSE:01349's Price-to-Tangible-Book is ranked better than
85.53% of 871 companies
in the Drug Manufacturers industry
Industry Median: 2.34 vs HKSE:01349: 0.92

A closely related ratio is called PB Ratio. As of today, Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co's share price is HK$2.18. Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co's Book Value per Sharefor the quarter that ended in Sep. 2023 was HK$2.40. Hence, Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co's P/B Ratio of today is 0.91.


Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Price-to-Tangible-Book Historical Data

The historical data trend for Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Price-to-Tangible-Book Chart

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Tangible-Book
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.32 1.76 1.58 1.48 1.07

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Quarterly Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Sep22 Dec22 Jun23 Sep23 Dec23
Price-to-Tangible-Book Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 1.48 1.10 1.11 1.07

Competitive Comparison of Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co's Price-to-Tangible-Book

For the Drug Manufacturers - Specialty & Generic subindustry, Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co's Price-to-Tangible-Book Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co's Price-to-Tangible-Book falls into.



Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Price-to-Tangible-Book Calculation

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book=Share Price/Tangible Book per Share (Q: Sep. 2023 )
=2.18/2.306
=0.95

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.


Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.


Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co (HKSE:01349) Business Description

Traded in Other Exchanges
Address
No. 308, Cai Lun Road, Zhangjiang Hi-Tech Park, Pudong, Shanghai, CHN, 201210
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd is engaged in the research, development, manufacturing, and sale of biopharmaceutical products. Its product portfolio includes ALA (Aminolevulinic acid Hydrochloride); FuMeiDa and Libord. Geographically, it derives revenue from Mainland China.

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co (HKSE:01349) Headlines

No Headlines